) channel blocker that binds with high affinity for SUR1 when co-expressed with Kir
= 0.42 nM). Antidiabetic glucose regulator with hypoglycaemic effect in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs.
Mark and Grell
Kir6.2-dependent high-affinity repaglinide binding to β-cell KATP channels.
Hansen et al.